PemVin vs Vin in Previously Treated Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 17, 2017

Primary Completion Date

December 5, 2023

Study Completion Date

April 15, 2024

Conditions

Breast Neoplasms

Interventions

DRUG

Pemetrexed + Vinorelbine

"Vinorelbine (25 mg/m2, day 1 \& 8)~* Pemetrexed (500 mg/m2, day 1)"

DRUG

Vinorelbine

Vinorelbine (25 mg/m2, day 1 \& 8)

Trial Locations (1)

Seoul National University Hospital, Seoul

All Listed Sponsors

lead

Seoul National University Hospital

OTHER

NCT03242616 - PemVin vs Vin in Previously Treated Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter